Key considerations for conducting Chinese medicine clinical trials in hospitals

Conducting clinical trials of Chinese medicines (CM) in hospitals presents challenges for researchers. The success of hospital-based CM clinical trials may be influenced by the protocol design, including the maintenance of CM theory in compliance with scientific rigour and hospital guidelines and justified treatment approaches with results that can translate into clinical practice. Other influences include personnel and resources such as a dedicated team open to CM with an established research culture and the ability to maximise participant recruitment. This article identifies the key challenges and limitations of conducting CM clinical trials in Australian hospitals.

• Publication year

  2013

• Venue

  Chinese Medicine

• Publication date

  2013-02-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.1186/1749-8546-8-3PMID 23414529PMCID 3577434
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Type of Multimorbidity and Complementary and Alternative Medicine Use among Adults

  2015cited by this paper
• ‘PANAX GINSENG C.A MEYER ROOT EXTRACT FOR MODERATE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD): STUDY PROTOCOL FOR A RANDOMISED CONTROLLED TRIAL’

  2014cited by this paper
• Panax ginseng C.A Meyer root extract for moderate Chronic Obstructive Pulmonary Disease (COPD): study protocol for a randomised controlled trial

  2011cited by this paper
• Acupuncture as analgesia for low back pain, ankle sprain and migraine in emergency departments: Study protocol for a randomized controlled trial

  2011cited by this paper
• Patients' preferences about participation in clinical trials studying complementary and alternative medicine.

  2011cited by this paper
• Recruitment to randomised trials: strategies for trial enrollment and participation study. The STEPS study.

  2007cited by this paper
• Recruitment and implementation strategies in randomised controlled trials of acupuncture and herbal medicine in women's health.

  2006cited by this paper
• Applying Evidence-Based Medicine to Traditional Chinese Medicine: Debate and Strategy

  2006cited by this paper
• The Integration of Complementary Therapies in Australian General Practice: Results of a National Survey

  2005cited by this paper
• Complementary and alternative medicine use among adults: United States, 2002.

  2004cited by this paper
• Complementary and alternative medicine use among adults: United States, 2002. Advance data from vital and health statistics, no. 343

  2004cited by this paper
• Willingness to Participate in Complementary and Alternative Medicine Clinical Trials Among Patients with Craniofacial Disorders

  2003cited by this paper
• Research into complementary and alternative medicine: problems and potential

  2001cited by this paper
• Canadians launch class action over E coli outbreak

  2000cited by this paper
• Barriers to participation in randomised controlled trials: a systematic review.

  1999cited by this paper
• (1996) Low Back Pain Evidence Review London: Royal College of General Practitioners

  1998cited by this paper

• Zao Ren An Shen for insomnia: a systematic review with meta-analysis.

  2020cites this paper
• Acupuncture for analgesia in the emergency department: a multicentre, randomised, equivalence and non‐inferiority trial

  2018cites this paper
• Acupuncture for analgesia in the emergency department: a multicentre, randomised, equivalence and non‐inferiority trial

  2017cites this paper
• Herbal Medicine in Nigeria : A Practice at the Clinical Crossroad

  2015cites this paper
• Panax ginseng therapy for chronic obstructive pulmonary disease: a clinical trial protocol and pilot study

  2014cites this paper
• ‘PANAX GINSENG C.A MEYER ROOT EXTRACT FOR MODERATE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD): STUDY PROTOCOL FOR A RANDOMISED CONTROLLED TRIAL’

  2014cites this paper
• Panax ginseng for Chronic Obstructive Pulmonary Disease (COPD)

  2013cites this paper